Inertial Microfluidic Purification of CAR‐T‐Cell Products-Reference-Cited by-同舟云学术

Inertial Microfluidic Purification of CAR‐T‐Cell Products

Published:2021-12-08 Issue:1 Volume:6 Page:2101018
ISSN:2701-0198
Container-title:Advanced Biology
language:en
Short-container-title:Advanced Biology

Author:

Elsemary Mona T.¹^ORCID,Maritz Michelle F.²^ORCID,Smith Louise E.³,Warkiani Majid⁴^ORCID,Bandara Veronika⁵^ORCID,Napoli Silvana⁵,Barry Simon C.⁵,Coombs Justin T.⁶,Thierry Benjamin²^ORCID

Affiliation:

1. Future Industries Institute ARC Centre of Excellence in Convergent Bio‐Nano Science and Technology Cell Therapy Manufacturing Cooperative Research Centre University of South Australia Mawson Lakes Campus Mawson Lakes SA 5095 Australia

2. Future Industries Institute ARC Centre of Excellence in Convergent Bio‐Nano Science and Technology University of South Australia Mawson Lakes Campus Mawson Lakes SA 5095 Australia

3. Future Industries Institute Cell Therapy Manufacturing Cooperative Research Centre University of South Australia Mawson Lakes Campus Mawson Lakes SA 5095 Australia

4. School of Biomedical Engineering University of Technology Sydney, Broadway Ultimo NSW 2007 Australia

5. Women's and Children's Hospital Adelaide SA 5006 Australia

6. Carina Biotech Adelaide SA 5095 Australia

Publisher

Wiley

Subject

General Biochemistry, Genetics and Molecular Biology,Biomedical Engineering,Biomaterials

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/adbi.202101018

Reference64 articles.

1. FDA approves first BCMA-targeted CAR-T cell therapy

2. FDA okays second CAR‐T for Kite ”https://www.nature.com/articles/s41587-020-0676-z(accessed: June2020).

3. National Cancer Institute FDA Approves Second CAR T‐Cell Therapy https://www.cancer.gov/news-events/cancer-currentsblog/2017/yescarta-fda-lymphoma(accessed: October2017).

4. S.Nam J.Smith G.Yang Driving the next wave of innovation in CAR T‐cell therapies | McKinsey https://www.mckinsey.com/industries/pharmaceuticals-and-medical-products/our-insights/drivingthe-next-wave-of-innovation-in-car-t-cell-therapies(accessed: July2019).

5. C.Scott CAR T‐Cell Manufacturing: Challenges Remain https://bioprocessintl.com/manufacturing/cell-therapies/challenges-andopportunities-in-car-t-cell-manufacturing/(accessed: July2020).

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SpiralDesigner: An AI-assisted design interface for efficient separation of neutrally buoyant and non-buoyant particles using spiral microfluidic devices;Chemical Engineering Science;2024-09

2. Role of Microfluidics in Drug Encapsulation for Point-of-care Diagnosis and Prognosis;Lab-on-a-chip Devices for Advanced Biomedicines;2024-08-14

3. Separation of Activated T Cells Using Multidimensional Double Spiral (MDDS) Inertial Microfluidics for High-Efficiency CAR T Cell Manufacturing;Analytical Chemistry;2024-06-18

4. Enrichment of T-lymphocytes from leukemic blood using inertial microfluidics toward improved chimeric antigen receptor-T cell manufacturing;Cytotherapy;2024-05

5. Biophysical and mechanobiological considerations for T-cell-based immunotherapy;Trends in Pharmacological Sciences;2023-06